Korea's SK bioscience plans Ph III COVID-19 vaccine trial in multiple countries

Clinical Trial Phase |  News | 0 Comment | 11 Aug, 2021

The International Vaccine Institute (IVI) is partnering with SK bioscience of South Korea to conduct Phase III clinical ...Read more

China approves first hormone replacement therapy for hypoparathyroidism

Clinical Trial Phase |  News | 0 Comment | 04 Jun, 2021

On account of World Hypopara Awareness Day on June 1st, VISEN Pharmaceuticals, a biotech company focused on developing a...Read more

GlobalData reports the status of Global COVID-19 vaccine trials

Clinical Trial Phase |  Analysis | 0 Comment | 08 Feb, 2021

While governments are ramping up vaccination programs, continued research into the effectiveness of the vaccines is impe...Read more

I-Mab reports efficacy of Anti-CD47 monoclonal Ab on relapsed/refractory malignancy

Clinical Trial Phase |  Company results | 0 Comment | 25 Nov, 2020

I-Mab, a global clinical-stage biopharmaceutical company based in China and the US and committed to the discovery, devel...Read more

Gilead’s Biktarvy sustains viral suppression and tolerability in Asian HIV patients

Clinical Trial Phase |  News | 0 Comment | 16 Oct, 2020

Gilead Sciences, Inc. on 15 Oct 2020 announced findings from multiple studies in Asian population that evaluated th...Read more